– USA, CA – Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced the appointment of Dr. Scott Kahn (Ph.D.) to its Board of Directors.
The company also announced that Brian Birk, Dr. Ebetuel Pallares, and Wendy Johnson will step down from the Board of Directors, effective the AGM on June 10th, 2024.
About Dr. Scott Kahn
Dr. Scott Kahn has a distinguished career in life sciences spending over 30 years in global leadership positions. Before starting his career in the life science industry, he was an assistant professor of organic chemistry at the University of Illinois. He spent over 10 years at the scientific software company, Accelrys, where he held several positions with increasing responsibility including SVP, General Manager and SO. He then joined Illumina as its first CIO and spent 12 years with the sequencing leader. He was most recently with LunaPBC as the Chief Information and Privacy Officer.
Dr. Scott Kahn holds Board positions at Blue Circle Health, Rady Children’s Institute for Genomic Medicine, and Rady Children’s Hospital.
Dr. Kahn received a B.S. in Chemistry from Rider College, a Ph.D. in Theoretical Organic Chemistry from the University of California, Irvine, and was a Fellow Commoner at Churchill College and a Postdoctoral Fellow at the University of Cambridge, England.
About Exagen
Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision-making to improve patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information: https://exagen.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.